Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  de Melo Maia, Beatriz ^a   Lavorato Rocha, André M ^a   Rodrigues, Iara S ^a   Baiocchi, Glauco ^a   Cestari, Flávia M ^a   Stiepcich, Monica M ^b   Chinen, Ludmila T D ^a   Carvalho, Kátia C ^c   Soares, Fernando A ^a   Rocha, Rafael M ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Fleury   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

c KIT; HPV; Immunohistochemistry; qRT PCR; Vulvar carcinoma

Indexed keywords

MESSENGER RNA; POLYCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; FROZEN SECTION; GENE EXPRESSION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY DEVICE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR PROBE; PAPILLOMAVIRUS INFECTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUALITY OF LIFE; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOCIAL PSYCHOLOGY; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; TISSUE MICROARRAY; VULVA CANCER; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 84867857345     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-150     Document Type: Article

References (33)

1. Buxant F, Anaf V, Haouari H. Rapid Groin Recurrence of a vulvar carcinoma with invasion of the femoral vessels and the importance of the inicial groin dissection in the staging surgery. Acta Chir Belg 2005, 105:418-419.
2. Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the U.S. Gynecol Oncol 2008, 108(Suppl 3):577-583. 2350205, 18155274.
3. Vulvar Cancer Key Statistics American Cancer Society http://www.cancer.org/Cancer/VulvarCancer/DetailedGuide/vulvar-cancer-key-statistics Last updated: 03/13/2012. Accessed on: 07/26/2012, Vulvar Cancer Key Statistics.
4. Jones RW, Baranyai J, Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 1997, 90:448-452. 10.1016/S0029-7844(97)00298-6, 9277660.
5. Lanneau GS, Argenta PA, Lanneau MS, et al. Vulvar cancer in young women: demographic features and outcome evaluation. Am J Obstet Gynecol 2009, 200:645.
6. Joura EA, Losch A, Haider-Angeler MG, et al. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2000, 45:613-615.
7. Berchuck A, Rodriguez G, Kamel A, et al. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol 1990, 76:381-387.
8. Maeda H, Yamagata A, Nishikawa S, et al. Requirement of c-KIT for development of intestinal pacemaker system. Development 1992, 116:369-375.
9. Krams M, Parwaresch R, Sipos B, et al. Expression of the c-KIT receptor characterizes a subset of neuroblastomas with favorable prognosis. Oncogene 2004, 23:588-595. 10.1038/sj.onc.1207145, 14724587.
10. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of c-KIT product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch 1994, 424:135-141.
11. Maffini MV, Soto AM, Sonnenschein C, et al. Lack of c-KIT receptor promotes mammary tumors in N-nitrosomethylurea-treated Ws/Ws rats. Cancer Cell Int 2008, 8:5. 10.1186/1475-2867-8-5, 2394517, 18445266.
12. Sperling C, Schwartz S, Buchner T, et al. Expression of the stem cell factor receptor c-KIT (CD117) in acute leukemias. Haematologica 1997, 82:617-621.
13. Lev S, Blechman JM, Givol D, Yarden Y. Steel factor and c-KIT protooncogene: genetic lessons in signal transduction. Crit Rev Oncog 1994, 5:141-168. 10.1615/CritRevOncog.v5.i2-3.30, 7531500.
14. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998, 152:1259-1269. 1858579, 9588894.
15. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol 2002, 26:493-497. 10.1097/00000478-200204000-00012, 11914628.
16. Schwartz S, Heinecke A, Zimmermann M, et al. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance. Leuk Lymphoma 1999, 34:85-94.
17. Hines SJ, Organ C, Kornstein MJ, Krystal GW. Coexpression of the c-KIT and stem cell factor genes in breast carcinomas. Cell Growth Differ 1995, 6:769-779.
18. Heinrich MC, Blanke CD, Druker BJ, Corless CL. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 2002, 20:1692-1703. 10.1200/JCO.20.6.1692, 11896121.
19. di Paola RS, Kuczynski WI, Onodera K, et al. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells. Cancer Gene Ther 1997, 4:176-182.
20. Bar-Sela G, Ben Arush MW, Sabo E, et al. Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults. Pediatr Blood Cancer 2005, 45:291-297. 10.1002/pbc.20264, 15558705.
21. Bataille R, Pellat-Deceunynck C, Robillard N, et al. CD117 (c-KIT) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis. Leuk Res 2008, 32:379-382. 10.1016/j.leukres.2007.07.016, 17767956.
22. Hasigawa T. Role of immunohistochemical expression of KIT/CD 117 in gastrointestinal stromal tumors. Handbook of immunohistochemistry and in situ hybridization of human carcinomas 2006, 135-142. San Diego: Elsevier Academic Press, Hayat MA.
23. Inoue M, Kyo S, Fujita M, et al. Coexpression of the c-KIT receptor and the stem cell factor in gynecological tumors. Cancer Res 1994, 54:3049-3053.
24. Huang S, Luca M, Gutman M, et al. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene 1996, 13:2339-2347.
25. Eroǧlu A, Sari{dotless} A, Eroglu N. Primary epithelioid sarcoma of the vulva in pregnancy. Gynecol Surg 2008, 5:61-64.
26. Jahn T, Seipel P, Coutinho S, et al. Analysing c-KIT internalization using a functional c-KIT-EGFP chimera containing the uorochrome within the extracellular domain. Oncogene 2002, 21:4508-4520. 10.1038/sj.onc.1205559, 12085229.
27. Rouzier R, Haddad B, Plantier F, et al. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 2002, 100:1159-1167. 10.1016/S0029-7844(02)02501-2, 12468158.
28. Caruana G, Cambareri AC, Ashman LK. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts. Oncogene 1999, 18:5573-5581. 10.1038/sj.onc.1202939, 10523834.
29. Kapur R, Cooper R, Zhang L, Williams DA. Cross-talk between alpha(4)beta(1)/alpha(5)beta(1) and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways. Blood 2001, 97:1975-1981. 10.1182/blood.V97.7.1975, 11264161.
30. Natali PG, Nicotra MR, Sures I, et al. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 1992, 52(Suppl 22):6139-6143. 15.
31. de Hullu JA, van der Zee AG. Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006, 60:38-58. 10.1016/j.critrevonc.2006.02.008, 16829120.
32. Holschneider CH, Berek JS. Câncer de vulva. Tratado de ginecologia 2002, 1234-1262. Rio de Janeiro: Guanabara Koogan, Berek JS, in portuguese.
33. Kumar S, Shah JP, Bryant CS, et al. A comparison of younger vs older women with vulvar cancer in the United States. Am J Obstet Gynecol 2009, 200:52-55.